Gerresheimer AG
ISIN: DE000A0LD6E6
WKN: A0LD6E
28 October 2025 04:10PM

EQS-News: Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen 

Gerresheimer AG · ISIN: DE000A0LD6E6 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2219976

EQS-News: Gerresheimer AG / Key word(s): Personnel
Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen 

28.10.2025 / 16:10 CET/CEST
The issuer is solely responsible for the content of this announcement.


Gerresheimer: Uwe Röhrhoff takes over as interim CEO for Dietmar Siemssen 

  • Industry expert with many years of experience in the sector, including around 26 years in management positions at Gerresheimer
  • Dietmar Siemssen to step down as CEO by mutual agreement with the Supervisory Board
  • New formation of the Management Board

Duesseldorf, October 28, 2025. The Supervisory Board of Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries has appointed Uwe Röhrhoff as interim CEO of the company's Management Board, effective November 1, 2025. He succeeds Dietmar Siemssen, who, by mutual agreement with the Supervisory Board, will step down as CEO of Gerresheimer AG on October 31, 2025. Uwe Röhrhoff is familiar with Gerresheimer from his previous 26 years with the company from 1991 to 2017. He was appointed to the Management Board in 2003 and served as CEO of Gerresheimer from 2010 to 2017. Most recently, he worked as a consultant and supervisory board member for various companies. The experienced industry expert holds supervisory board mandates at Klöckner & Co. SE and Röchling SE & Co. KG, among others. The appointment of Uwe Röhrhoff as interim CEO completes the new formation of Gerresheimer's Management Board for the time being.

“We are delighted to have gained Uwe Röhrhoff, a proven industry expert, as interim CEO,” said Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG. “As former CEO of Gerresheimer, he is extremely knowledgeable about the company and has a very clear understanding of the business and its challenges.”

Dietmar Siemssen steps down as CEO after seven years

Röhrhoff succeeds Dietmar Siemssen, who, by mutual agreement with the Supervisory Board, will step down as CEO on October 31, after seven years in office. He is thus paving the way for a personnel change at the top of the MDAX company.

“We would like to thank Dietmar Siemssen for his commitment and contribution to the strategic development of Gerresheimer,” said Dr. Axel Herberg. “Under his leadership, the company has transformed itself from a volume supplier to a provider of high-value systems and solutions for the pharma and biotech industries.”

Newly formed Management Board

The appointment of Uwe Röhrhoff as interim CEO completes the personnel changes to Gerresheimer's Management Board for the time being. In September 2025, Wolf Lehmann replaced Dr. Bernd Metzner as CFO. On November 1, 2025, Uwe Röhrhoff will succeed Dietmar Siemssen as CEO and Achim Schalk will succeed Dr. Lukas Burkhard as a member of the Management Board.

 

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma, the Group generated revenues of around EUR 2.4bn in 2024 and currently employs around 13,600 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).    
www.gerresheimer.com 

 

Contact Gerresheimer AG

Media  
Jutta Lorberg
Head of Corporate Communication
T +49 211 6181 264
jutta.lorberg@gerresheimer.com                   
Marion Stolzenwald
Senior Manager Corporate Communication
T +49 172 2424185
marion.stolzenwald@gerresheimer.com
 
Investor Relations
 
Guido Pickert
Vice President Investor Relations
T +49 211 6181 220
gerresheimer.ir@gerresheimer.com
 
Thomas Rosenke
Senior Manager Investor Relations
T +49 211 6181-187
gerresheimer.ir@gerresheimer.com


28.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Gerresheimer AG
Peter-Müller-Str. 3
40468 Duesseldorf
Germany
Phone: +49-(0)211/61 81-00
Fax: +49-(0)211/61 81-121
E-mail: gerresheimer.ir@gerresheimer.com
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2219976

 
End of News EQS News Service

2219976  28.10.2025 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2019 2020 2021 2022 2023 2024 2025e
Sales1 1.392,26 1.418,79 1.498,01 1.817,09 1.990,49 2.035,90 1.974,00
EBITDA1,2 400,01 310,14 306,31 340,87 399,42 396,00 368,00
EBITDA-Margin3 28,73 21,86 20,45 18,76 20,07 19,45 18,64
EBIT1,4 123,76 156,46 147,44 169,31 213,39 197,47 175,00
EBIT-Margin5 8,89 11,03 9,84 9,32 10,72 9,70 8,87
Net Profit (Loss)1 82,68 89,88 87,24 102,19 120,09 112,32 76,00
Net-Margin6 5,94 6,34 5,82 5,62 6,03 5,52 3,85
Cashflow1,7 192,92 222,19 212,08 221,94 294,34 240,33 0,00
Earnings per share8 2,57 2,82 2,67 3,06 3,48 2,56 2,10
Dividend per share8 1,20 1,25 1,25 1,25 1,25 0,04 0,50
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: KPMG

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Gerresheimer
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A0LD6E DE000A0LD6E6 AG 906,33 Mio € 11.06.2007 Halten 9F387QF9+73
* * *
PE 2026e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
10,29 23,13 0,44 7,97 0,60 3,77 0,45
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
1,25 0,04 0,50 1,93%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
03.06.2026 16.04.2026 14.07.2026 10.10.2025 26.02.2026
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
-1,45%
25,86 €
ATH 122,90 €
-14,48% -45,57% -63,58% -65,52% -35,35%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL